- Home
- ACIU vs VIRC Comparison
ACIU vs VIRC Comparison
Compare ACIU & VIRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- VIRC
- Stock Information
- Founded
- ACIU 2003
- VIRC 1950
- Country
- ACIU Switzerland
- VIRC United States
- Employees
- ACIU N/A
- VIRC N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- VIRC Industrial Specialties
- Sector
- ACIU Health Care
- VIRC Consumer Discretionary
- Exchange
- ACIU Nasdaq
- VIRC Nasdaq
- Market Cap
- ACIU 173.7M
- VIRC 158.2M
- IPO Year
- ACIU 2016
- VIRC N/A
- Fundamental
- Price
- ACIU $1.68
- VIRC $8.70
- Analyst Decision
- ACIU Strong Buy
- VIRC Buy
- Analyst Count
- ACIU 2
- VIRC 1
- Target Price
- ACIU $10.00
- VIRC $19.00
- AVG Volume (30 Days)
- ACIU 137.1K
- VIRC 105.3K
- Earning Date
- ACIU 04-30-2025
- VIRC 06-06-2025
- Dividend Yield
- ACIU N/A
- VIRC 1.12%
- EPS Growth
- ACIU N/A
- VIRC N/A
- EPS
- ACIU N/A
- VIRC 1.32
- Revenue
- ACIU $32,014,254.00
- VIRC $266,240,000.00
- Revenue This Year
- ACIU N/A
- VIRC $3.63
- Revenue Next Year
- ACIU $676.94
- VIRC $2.60
- P/E Ratio
- ACIU N/A
- VIRC $6.76
- Revenue Growth
- ACIU 91.20
- VIRC N/A
- 52 Week Low
- ACIU $1.43
- VIRC $8.13
- 52 Week High
- ACIU $4.98
- VIRC $18.50
- Technical
- Relative Strength Index (RSI)
- ACIU 46.75
- VIRC 41.35
- Support Level
- ACIU $1.55
- VIRC $8.13
- Resistance Level
- ACIU $1.79
- VIRC $8.99
- Average True Range (ATR)
- ACIU 0.10
- VIRC 0.34
- MACD
- ACIU 0.03
- VIRC -0.06
- Stochastic Oscillator
- ACIU 66.67
- VIRC 34.05
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About VIRC Virco Manufacturing Corporation
Virco Manufacturing Corp is engaged in designing, production and distributing quality furniture for the commercial and education markets. The company manufactures an assortment of products, including mobile tables, mobile storage equipment, desks, computer furniture, chairs, and activity tables, folding chairs, and folding tables. Its primary furniture lines are constructed of tubular metal legs and frames, combined with wood and plastic tops, plastic seats and backs, upholstered seats and backs, and upholstered rigid polyethylene and polypropylene shells.